Cargando…

Clinical burden of illness among patients with severe eosinophilic COPD

Background: There are currently limited real-world data on the clinical burden of illness in patients with COPD who continue to exacerbate despite receiving triple therapy. The aim of this study was to compare the burden of COPD in patients with and without a phenotype characterized by a high blood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müllerová, Hana, Meeraus, Wilhelmine H, Galkin, Dmitry V, Albers, Frank C, Landis, Sarah H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497493/ https://www.ncbi.nlm.nih.gov/pubmed/31114180 http://dx.doi.org/10.2147/COPD.S194511

Ejemplares similares

Terms and Definitions Used to Describe Recurrence, Treatment Failure and Recovery of Acute Exacerbations of COPD: A Systematic Review of Observational Studies
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021)

Predicting Re-Exacerbation Timing and Understanding Prolonged Exacerbations: An Analysis of Patients with COPD in the ECLIPSE Cohort
por: Meeraus, Wilhelmine H, et al.
Publicado: (2021)

Treatment Patterns of New Users of Fluticasone Furoate/Vilanterol in Asthma and COPD in UK Primary Care: Retrospective Cohort Study
por: Dedman, Daniel, et al.
Publicado: (2019)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
por: Benson, Victoria S, et al.
Publicado: (2019)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
por: Müllerová, Hana, et al.
Publicado: (2019)

COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners
por: Meeraus, Wilhelmine, et al.
Publicado: (2018)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Primary data, claims data, and linked data in observational research: the case of COPD in Germany
por: Mueller, Sabrina, et al.
Publicado: (2018)

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
por: Liu, Mark C., et al.
Publicado: (2021)

Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort
por: Trudo, Frank, et al.
Publicado: (2019)

Burden of disease associated with a COPD eosinophilic phenotype
por: Ortega, Hector, et al.
Publicado: (2018)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting
por: Whittaker, Hannah R, et al.
Publicado: (2019)

Association between Antibiotic Prescribing in Pregnancy and Cerebral Palsy or Epilepsy in Children Born at Term: A Cohort Study Using The Health Improvement Network
por: Meeraus, Wilhelmine Hadler, et al.
Publicado: (2015)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

Nemiralisib in Patients with an Acute Exacerbation of COPD: Placebo-Controlled, Dose-Ranging Study
por: Fahy, William A, et al.
Publicado: (2021)

Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013
por: Landis, Sarah H, et al.
Publicado: (2014)

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey
por: Müllerová, Hana, et al.
Publicado: (2016)

Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting
por: Chastek, Benjamin, et al.
Publicado: (2016)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization
por: Viinanen, Arja, et al.
Publicado: (2019)

Extending the data collection from a clinical trial: The Extended Salford Lung Study research cohort
por: Meeraus, Wilhelmine, et al.
Publicado: (2023)

Stability in eosinophil categorisation during subsequent severe exacerbations of COPD
por: Citgez, Emanuel, et al.
Publicado: (2021)

Methods to generate and validate a Pregnancy Register in the UK Clinical Practice Research Datalink primary care database
por: Minassian, Caroline, et al.
Publicado: (2019)

Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort
por: Hastie, AT, et al.
Publicado: (2017)

Oral corticosteroid dose changes and impact on peripheral blood eosinophil counts in patients with severe eosinophilic asthma: a post hoc analysis
por: Prazma, Charlene M., et al.
Publicado: (2019)

Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2015)

Eosinophilic airway inflammation in COPD
por: Saha, Shironjit, et al.
Publicado: (2006)

Precision medicine in COPD: review of mepolizumab for eosinophilic COPD
por: Long, Gabriella, et al.
Publicado: (2018)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
por: Eltboli, Osama, et al.
Publicado: (2014)

The association between eosinophilic exacerbation and eosinophilic levels in stable COPD
por: Kang, Hye Seon, et al.
Publicado: (2021)

Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study
por: Müllerová, Hana, et al.
Publicado: (2014)

Fibrinogen, chronic obstructive pulmonary disease (COPD) and outcomes in two United States cohorts
por: Valvi, Deepa, et al.
Publicado: (2012)

Fungal sensitization and its relationship to mepolizumab response in patients with severe eosinophilic asthma
por: Wardlaw, Andrew, et al.
Publicado: (2020)

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma
por: Kolsum, Umme, et al.
Publicado: (2017)

Blood Eosinophils and Pulmonary Rehabilitation in COPD
por: Aljazeeri, Jafar, et al.
Publicado: (2021)

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care
por: Rothnie, Kieran J, et al.
Publicado: (2017)

Prevalence and Burden of Breathlessness in Patients with Chronic Obstructive Pulmonary Disease Managed in Primary Care
por: Müllerová, Hana, et al.
Publicado: (2014)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022)

Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO
por: Pavord, Ian D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3sn8pj16609f58gti8nskfqnn3